alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › testing

testing

4 studies tagged testing, dated 2015-08-10 to 2025-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studies 2025-01-01
  2. Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study 2019-08-24
  3. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease 2018-10-10

Studies

4 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Alzheimer's & dementia (New York, N. Y.) 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • BMJ open 1
  • International journal of geriatric psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studies

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia (New York, N. Y.) 2025-01-01 Biomarkers

    The choice of prescreening strategy in AD prevention studies/trials should be tailored to specific trial requirements, considering the relative importance of sensitivity versus cost-effectiveness, local testing cost environments, and background population characteristics.

  2. Media Coverage of the Benefits and Harms of Testing the Healthy: a protocol for a descriptive study

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. BMJ open 2019-08-24 Biomarkers

    Much testing in medicine is aimed at healthy people to facilitate the early detection of health conditions.

  3. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2018-10-10 Tau biomarkers

    In anticipation of the emergence of more reliable CSF analysis platforms, the manuscript offers important guidance to health-care practitioners and suggestions for implementation and future research.

  4. Attitudes to Alzheimer's disease testing of Australian general practice patients: a cross-sectional questionnaire-based study

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. International journal of geriatric psychiatry 2015-08-10 Biomarkers

    This study demonstrates that a majority of patients would like to know if they have AD.

All topic tags with their study counts